Direct Versus Indirect Pick up of the Locator Retentive Caps:(Within-patient Study)

April 19, 2023 updated by: Mansoura University

Direct Versus Indirect Pick up of the Locator Retentive Caps for Two Implant-retained Mandibular Overdenture: Calibration of the Manufacturer Retentive Force and the Clinical Retention (Within-patient Study)

The purpose of this study will be to evaluate the effect of direct and indirect pick up of the locator retentive caps and compare the clinical results with those of the manufacturer retentive force.

Study Overview

Detailed Description

Patient selection:

For this study, 30 patients were selected from the clinic of Prosthodontic Department, Faculty of Dentistry, Mansoura University.

According to pick up technique for the locator retentive caps, the overdentures will be classified into two groups as follows; Group1: The retentive caps will be picked up by indirect method on the cast then by the direct method Group2: The retentive caps will be picked up in the patient by the direct method first then by the indirect method.

For both groups, the clinical retention will be measured after using pink and blue retentive inserts respectively.

All implants were inserted using computer-guided implant surgery and conventional loading protocol was used.

Evaluation methods The clinical retention of each insert will be calibrated as regards the manufacturer's value.

Also, the laboratory retention will be assessed for the two groups and calibrated as regards the manufacturer's value.

Measurements will be done immediately, three and six months after each overdenture insertion.

Study Type

Interventional

Enrollment (Actual)

30

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Mansoura, Egypt, P.O.Box:35516
        • Christine Ibrahim

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

40 years to 70 years (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • ● Free from any systemic disease that may interfere with the osseointegration of implants.

    • Patients will have completely edentulous maxilla and mandible for at least 6 months after the last extraction.
    • Patients will have normal maxilla mandibular relationships.
    • Mandibular arch with residual alveolar ridges covered with firmly attached mucosa.
    • The width of the mandibular ridge in the canine area will be sufficient for the installation of the implants in parallel anteroposterior and mesiodistal directions.

Exclusion Criteria:

  • medically compromised patients smokers uncontrolled metabolic diseases ( diabetes mellitus ) uncooperative patients

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Crossover Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Group I
GroupI: The retentive caps will be picked up by the indirect method on the cast first, then by the direct method.
placement of two interforaminal dental implants in the canine region in the mandible
placement of locator attachment and insertion of mandibular overdenture
Active Comparator: Group II
GroupII: The retentive caps will be picked up by the direct method on the cast first, then by the indirect method.
placement of two interforaminal dental implants in the canine region in the mandible
placement of locator attachment and insertion of mandibular overdenture

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
measurement of overdenture retention
Time Frame: three months
measuring the clinical retention of the locator retained mandibular overdenture by forcemeter
three months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
marginal bone loss
Time Frame: one year
measuring crestal bone loss around dental implants in mm by digital radiography
one year
plaque index
Time Frame: one year
measuring plaque around dental implants using scoring system: score 0; absence plaque , score 1; plaque only detected by a probe passing through the smooth marginal surface of the implant, score 2; plaque can be recognized by naked eye, and score 3; plenty of soft matter.
one year
gingival index
Time Frame: one year
measuring gingival bleeding using scoring system: 0; no bleeding when a periodontal probe is passed along the mucosal margin, 1;isolated bleeding spots visible, 2; blood forms a confluent red line on the mucosal margin, 3;heavy or profuse bleeding
one year
pocket depth
Time Frame: one year
measuring pocket depth around dental implants in mm using periodontal probe
one year

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

August 30, 2021

Primary Completion (Actual)

August 7, 2022

Study Completion (Actual)

March 16, 2023

Study Registration Dates

First Submitted

February 27, 2022

First Submitted That Met QC Criteria

March 11, 2022

First Posted (Actual)

March 21, 2022

Study Record Updates

Last Update Posted (Actual)

April 20, 2023

Last Update Submitted That Met QC Criteria

April 19, 2023

Last Verified

February 1, 2023

More Information

Terms related to this study

Other Study ID Numbers

  • A17030821

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Prosthesis Durability

Clinical Trials on dental implants in the mandible

Subscribe